A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.
A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010 Jun 01; 116(11):2543-8.